ASCO 2022 IMMUNIB Trial: A Single-Arm, Phase II Study Evaluating Safety & Efficacy of Nivo in Combination With Lenvatinib in Advanced Stage HCC | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

ASCO 2022 Conference Coverage

ASCO 2022 IMMUNIB Trial: A Single-Arm, Phase II Study Evaluating Safety & Efficacy of Nivo in Combination With Lenvatinib in Advanced Stage HCC

By ASCO 2022 Conference Coverage FEATURING Arndt Vogel

By ASCO 2022 Conference Coverage FEATURING Arndt Vogel

343 views

June 15, 2022

Comments 0

Login to view comments. Click here to Login